====== Linda Mah ======

{{ ::lindamah_1.jpeg?200|}}

**Linda Mah**, MD, MHSc, FRCPC, is a Canadian Clinician Scientist at the [[Rotman Research Institute]], [[Baycrest Health Sciences]], an Associate Professor in Psychiatry, Division of Geriatric Psychiatry at the [[University of Toronto]], and an Associate Member of the Institute of Medical Science, Faculty of Medicine, University of Toronto.((//About Us.// Ontario COVID-19 Science Advisory Table. Retrieved January 25, 2022, from https://covid19-sciencetable.ca/about/#mah-linda-2))

She is notable in the [[COVID-19 pandemic]] for her role on the [[Ontario COVID-19 Science Advisory Table]].

===== Education =====

Dr. Mah obtained her MD at the [[University of Calgary]] and completed a psychiatric residency at [[McGill University]], followed by clinical neuropsychiatry specialty training at the [[University of Massachusetts]] and formal research training in cognitive and affective neurosciences at the [[National Institutes of Health]], Bethesda, Maryland, USA. She has a Master of Health Sciences degree from [[Duke University]], USA, where she attended from 2003-2006.((//About Us.// Ontario COVID-19 Science Advisory Table. Retrieved January 25, 2022, from https://covid19-sciencetable.ca/about/#mah-linda-2)) ((Mah, L. (2019). //Curriculum Vitae.// Rotman Research Institute. https://www.rotman-baycrest.on.ca/files/employeeprofilemodule/@random49e4b2c2c6443/MAH_WebCV_July_31_2019_RRI.pdf))

===== Affiliations =====

==== Academy of Consultation-Liaison Psychiatry ====

In 1998 - 1999, Mah worked as a member of the Fellowships and Awards Committee of the [[Academy of Consultation-Liaison Psychiatry]] (also known as the Academy of Psychosomatic Medicine) in Bathesda, Maryland.((Mah, L. (2019). //Curriculum Vitae.// Rotman Research Institute. https://www.rotman-baycrest.on.ca/files/employeeprofilemodule/@random49e4b2c2c6443/MAH_WebCV_July_31_2019_RRI.pdf))

==== Baycrest Health Sciences ====

Mah is a Clinician Scientist at the Rotman Research Institute at [[Baycrest Health Sciences]] in the North York district of Toronto, Ontario.((//Dr. Linda Mah.// Baycrest Centre. Retrieved January 25, 2022, from https://archive.ph/eXS9Q)) She is also a Staff Psychiatrist at Baycrest.((Mah, L. (2019). //Curriculum Vitae.// Rotman Research Institute. https://www.rotman-baycrest.on.ca/files/employeeprofilemodule/@random49e4b2c2c6443/MAH_WebCV_July_31_2019_RRI.pdf))

==== Canadian Psychiatric Association ====

In 1996 - 1997, Mah served as Corresponding Member of the Efficacy and Cost-effectiveness Working Group, Steering Committee on the Psychotherapies for the [[:Canadian Psychiatric Association]].
==== Centre for Addiction and Mental Health ====

Mah also acted as a Staff Psychiatrist in the Adult Neurodevelopment and Geriatric Psychiatry Division at the [[Centre for Addiction and Mental Health]] (CAMH).((Mah, L. (2019). //Curriculum Vitae.// Rotman Research Institute. https://www.rotman-baycrest.on.ca/files/employeeprofilemodule/@random49e4b2c2c6443/MAH_WebCV_July_31_2019_RRI.pdf))

==== National Institutes of Health ====

Mah worked as a Staff Physician at the [[Warren Grant Magnuson Clinical Center]] under the [[National Institutes of Health]] in Bathesda, Maryland from 2000-2006.((Mah, L. (2019). //Curriculum Vitae.// Rotman Research Institute. https://www.rotman-baycrest.on.ca/files/employeeprofilemodule/@random49e4b2c2c6443/MAH_WebCV_July_31_2019_RRI.pdf))

She received a Fellows Award for Research Excellence from the [[National Institute of Mental Health]] in 2005.

==== Ontario COVID-19 Science Advisory Table ====

Mah is a member of the [[Ontario COVID-19 Science Advisory Table]], and a Co-Chair of the Mental Health Working Group.((//About Us.// Ontario COVID-19 Science Advisory Table. Retrieved January 25, 2022, from https://covid19-sciencetable.ca/about/#mah-linda-2))

==== University of Waterloo ====

From September 1987 until April 1988, Mah worked as a part-time research assistant in the Department of Psychology at the [[University of Waterloo]] under Dr. [[Kathleen Bloom]]. She returned in May 1991 to complete three further months of research funded by the [[Natural Sciences and Engineering Research Council of Canada]] (NSERC), under Dr. [[Phil Bryden]].((Mah, L. (2019). //Curriculum Vitae.// Rotman Research Institute. https://www.rotman-baycrest.on.ca/files/employeeprofilemodule/@random49e4b2c2c6443/MAH_WebCV_July_31_2019_RRI.pdf))

==== University of Toronto ====

Mah is an Associate Professor in Psychiatry, Division of Geriatric Psychiatry at the [[University of Toronto]], and an Associate Member of the Institute of Medical Science, Faculty of Medicine, University of Toronto.((//About Us.// Ontario COVID-19 Science Advisory Table. Retrieved January 25, 2022, from https://covid19-sciencetable.ca/about/#mah-linda-2)) She received $150,000.00 as an Academic Scholar Award from the Department of Psychiatry in 2018.((Mah, L. (2019). //Curriculum Vitae.// Rotman Research Institute. https://www.rotman-baycrest.on.ca/files/employeeprofilemodule/@random49e4b2c2c6443/MAH_WebCV_July_31_2019_RRI.pdf))

==== Worcester State Hospital ====

In her //curriculum vitae//, Mah describes having worked as a Staff Psychiatrist at the [[Worcester State Hospital]] in Worcester, Massachusetts from 1999-2000.((Mah, L. (2019). //Curriculum Vitae.// Rotman Research Institute. https://www.rotman-baycrest.on.ca/files/employeeprofilemodule/@random49e4b2c2c6443/MAH_WebCV_July_31_2019_RRI.pdf))

===== Societies and Associations =====

Man is a member of various societies and associations relevant to her field.((Mah, L. (2019). //Curriculum Vitae.// Rotman Research Institute. https://www.rotman-baycrest.on.ca/files/employeeprofilemodule/@random49e4b2c2c6443/MAH_WebCV_July_31_2019_RRI.pdf))

^ Name  ^ Dates Active  ^ Notes  ^
| [[Alzheimer's Association International Society to Advance Alzheimer's Research and Treatment]] (ISTAART)  | 2018 - present  | -  |
| [[Organization for Human Brain Mapping]]  | 2018 - present  | -  |
| [[Federation of Medical Women of Canada]]  | 2018 - present  | -  |
| [[Canadian Association for Geriatric Psychiatry]]  | 2015 - present  | Member, Research Committee. Markham, Ontario, Canada.  |
| [[Society for Biological Psychiatry]]  | 2010 - 2016  | -  |
| [[American Association of Geriatric Psychiatry]]  | 2007 - present  | -  |
| [[Society for Neuroscience]]  | 2004 - present  | -  |
| [[Cognitive Neuroscience Society]]  | 2002 - 2006  | -  |
| [[American Neuropsychiatric Association]] | 1998 - 2006  | Member, Program and Education Committees. Houston, Texas, United States of America  |

===== Research =====

Dr. Mah’s research program focuses on understanding the relationship between cognition and emotion and their neuroanatomical correlates in healthy aging and in disorders of the elderly, including late-life depression (LLD), mild cognitive impairment (MCI), and Alzheimer’s disease (AD). 

Her research employs converging methods including behavioural paradigms, neuropsychological assessment, neuroimaging, and more recently, psychophysiology. She has a particular interest in examining emotion dysregulation and other neuropsychiatric symptoms as potential biomarkers of AD risk, and in understanding the link between stress and development of AD. 

Dr. Mah is also the primary investigator (or site investigator) on clinical trials focused on treatment-refractory depression in older adults and studies using brain stimulation as an intervention for cognitive decline in older adults at risk for developing AD, including those with remitted depression, subjective cognitive decline (SCD) or MCI.

She is an Associate Editor for the [[Journal of Alzheimer’s Disease]].((//About Us.// Ontario COVID-19 Science Advisory Table. Retrieved January 25, 2022, from https://covid19-sciencetable.ca/about/#mah-linda-2))

==== COVID-19 ====

Mah took part in joint research with [[Baycrest Health Sciences]]'s Rotman Research Institute and the [[Centre for Addiction and Mental Health]] (CAMH) studying the impact of [[COVID-19]] and physical distancing measures on older adults' mental health, funded by the [[Ontario Ministry of Health and Long-Term Care]] Academic Health Science Centre (AHSC) Alternative Funding Plan (AFP) Innovation Fund.((Mah, L. (2021). //Declaration of Interest.// Ontario COVID-19 Science Advisory Table. https://covid19-sciencetable.ca/wp-content/uploads/2021/04/Declaration-of-Interest_Mental-Health-Working-Group_Linda-Mah_20210827.pdf))
==== Funding ====

Dr. Mah’s work has been primarily funded by the [[Alzheimer’s Society of Canada]], [[Brain Canada]], and the [[Centre for Aging and Brain Health Innovation]].((//About Us.// Ontario COVID-19 Science Advisory Table. Retrieved January 25, 2022, from https://covid19-sciencetable.ca/about/#mah-linda-2)) Further research funding has come from the [[National Institute of Mental Health]] and [[The Scottish Rite Charitable Foundation]].((Breitberg, A., Drevets, W. C., Wood, S. E., Mah, L., Schulkin, J., Sahakian, B. J., & Erickson, K. (2013). //Hydrocortisone infusion exerts dose- and sex-dependent effects on attention to emotional stimuli.// Brain and Cognition, 81(2), 247–255. https://doi.org/10.1016/j.bandc.2012.10.010)) ((Mah, L., Zarate, C. A., Nugent, A. C., Singh, J. B., Manji, H. K., & Drevets, W. C. (2011). //Neural mechanisms of antidepressant efficacy of the dopamine receptor agonist pramipexole in treatment of bipolar depression.// International Journal of Neuropsychopharmacology, 14(4), 545–551. https://doi.org/10.1017/s1461145710001203))